Sunshine A, Olson N Z, Zighelboim I, De Castro A
New York University Medical Center, Analgesic Development Ltd., New York 10021.
Clin Pharmacol Ther. 1993 Nov;54(5):546-55. doi: 10.1038/clpt.1993.187.
Ketoprofen (Orudis) is a nonsteroidal anti-inflammatory drug that is currently approved in the United States for the management of mild to moderate pain. The objective of this trial was to determine the effectiveness of orally administered ketoprofen in the management of severe postoperative pain. This randomized, double-blind parallel study compared the efficacy and safety of single doses of 100 mg or 50 mg ketoprofen, the combination of 650 mg acetaminophen plus 10 mg oxycodone hydrochloride, 650 mg acetaminophen, or placebo in 240 patients with severe postoperative pain after cesarean section. Analgesia for the first dose was assessed over an 8-hour period. Multiple doses of 100 mg or 50 mg ketoprofen and the combination at half the dose (325 mg acetaminophen plus 5 mg oxycodone) were also assessed for up to 7 days. The 100 and 50 mg doses of ketoprofen and the combination were statistically superior to acetaminophen and placebo for many analgesic measures. A dose response was observed between the two doses of ketoprofen, with the 100 mg dose providing significantly greater analgesia over the lower dose. Ketoprofen, 100 mg, was at least as effective as the combination and its effects lasted longer, with the exception of hour 1 when the combination was superior. Remedication time for the group receiving 100 mg ketoprofen was significantly longer than for the other treatment groups. Significantly more patients who took repeated doses of the combination (84%) than those who took either dose of ketoprofen (70%) had adverse effects. Ketoprofen at both dose levels was shown to be effective, long-lasting, and well tolerated, and it should be considered as a viable option for the management of moderate to severe postoperative pain.
酮洛芬(奥鲁地)是一种非甾体抗炎药,目前在美国被批准用于治疗轻至中度疼痛。本试验的目的是确定口服酮洛芬治疗严重术后疼痛的有效性。这项随机、双盲平行研究比较了单剂量100毫克或50毫克酮洛芬、650毫克对乙酰氨基酚加10毫克盐酸羟考酮的组合、650毫克对乙酰氨基酚或安慰剂在240例剖宫产术后严重疼痛患者中的疗效和安全性。在8小时内评估首剂镇痛效果。还评估了多剂量100毫克或50毫克酮洛芬以及半量组合(325毫克对乙酰氨基酚加5毫克羟考酮)长达7天的情况。在许多镇痛指标上,100毫克和50毫克剂量的酮洛芬以及该组合在统计学上优于对乙酰氨基酚和安慰剂。在两种剂量的酮洛芬之间观察到剂量反应,100毫克剂量比低剂量提供了显著更强的镇痛效果。100毫克酮洛芬至少与该组合一样有效,且其效果持续时间更长,但在第1小时该组合更优。接受100毫克酮洛芬组的补救用药时间明显长于其他治疗组。服用该组合重复剂量的患者(84%)出现不良反应的比例明显高于服用任何一种剂量酮洛芬的患者(70%)。两种剂量水平的酮洛芬均显示有效、持久且耐受性良好,应被视为治疗中度至重度术后疼痛的可行选择。